Eltropag 25mg Tablet: Effective Medication for Your Health

Eltropag 25mg Tablet

Uses:

• Treatment of low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
• Treatment of severe aplastic anaemia.

Mechanism of action:

• Stimulates megakaryocytes (large bone marrow cells) responsible for producing platelets.
• Raises the number of platelets in the blood, preventing bleeding and bruising.

Important information:

• Contraindicated in individuals with hypersensitivity to the drug or its components.
• Not recommended for use in patients with severe liver impairment or active liver disease.
• Regular monitoring of platelet count is required.
• High platelet counts can increase the risk of blood clotting.
• Do not take with dairy products or drinks, as calcium in these items affects the absorption of the medicine.
• Use effective birth control during treatment.
• Not advised for children under one with ITP, and not recommended for patients under 18 with low platelet counts caused by hepatitis C or severe aplastic anaemia.

Safety advice:

• Pregnancy: not recommended due to potential fetal harm.
• Breastfeeding: consult a doctor.
• Lungs: consult a doctor if you have lung diseases.
• Liver: cautiously administered in patients with severe liver diseases.
• Alcohol: consult a doctor if you drink alcoholic beverages.
• Driving: avoid driving vehicles or operating heavy machinery after taking the medication.

Side effects:

• Common side effects include nausea, diarrhea, abdominal pain, common cold, cough, respiratory tract infection, back pain, high temperature, loss of appetite, hair loss, swelling in feet or hands, headache, dizziness, mouth and throat pain, joint pain.

FAQ:

• Q: What is ITP? A: Immune thrombocytopenia (ITP) is a rare blood disorder characterized by insufficient platelets in the blood.
• Q: Who should not use the Eltropag 25mg Tablet? A: People with ITP, children under one, and individuals with severe aplastic anemia and hepatitis C should not use the medication.
• Q: Will you be monitored during treatment with the Eltropag 25mg Tablet? A: Yes, regular monitoring of white blood cell count, platelets, blood clotting factors, heart rate, eye tests, and complete blood count is required.
• Q: Is it safe to take the Eltropag 25mg Tablet on an empty stomach? A: Yes, the medication should be taken on an empty stomach to avoid interference with absorption by antacids, mineral and vitamin supplements, dairy products, and calcium-enriched foods.
• Q: What happens if you discontinue using the Eltropag 25mg Tablet? A: Discontinuing the medication suddenly can lead to a decrease in platelet count, potentially resulting in severe bleeding. Consult a healthcare practitioner before stopping the medication.
• Q: How to store Eltropag 25mg Tablet? A: Store at room temperature (25°C) and out of reach of children. Do not use after the expiration date.

Fact box:

• Molecule name: Eltrombopag
• Therapeutic class: Anticoagulant
• Pharmacological class: Thrombopoietin (TPO) receptor agonist
• Indications:
  • Low platelet counts caused by immune primary thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
  • Severe aplastic anaemia.

Tags: Eltropag, medication, 25mg, tablet, health, pharmacy, drug, hypertension, treatment